Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024

BUY
$17.75 - $41.6 $33,725 - $79,040
1,900 New
1,900 $75,000
Q4 2021

Jan 24, 2022

BUY
$10.41 - $13.95 $57,255 - $76,725
5,500 New
5,500 $76,000
Q3 2021

Oct 22, 2021

SELL
$8.19 - $11.31 $22,113 - $30,537
-2,700 Closed
0 $0
Q2 2021

Jul 26, 2021

BUY
$8.81 - $15.03 $23,787 - $40,581
2,700 New
2,700 $24,000

Others Institutions Holding ALPN

About ALPINE IMMUNE SCIENCES, INC.


  • Ticker ALPN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 44,006,700
  • Description
  • Alpine Immune Sciences, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of protein-based immunotherapies for the treatment of cancer, autoimmune/inflammatory disorders, and other diseases. Its product pipeline includes ALPN-101, an inducible T cell costimulator (ICOS)/cluster of differentiation 28 (CD28...
More about ALPN
Track This Portfolio

Track Strs Ohio Portfolio

Follow Strs Ohio and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Strs Ohio, based on Form 13F filings with the SEC.

News

Stay updated on Strs Ohio with notifications on news.